Name | 2,4-Dichloro-5-nitropyridine |
Synonyms | T6NJ BG DG ENW [WLN] 2,4-Dichloro-5-nitropyridine 2,4-DICHLORO-5-NITROPYRIDINE 5-nitro-2,4-dichloro pyridine 2,4-DIHYDROXY-5-NITROPYRIDINE Pyridine, 2,4-dichloro-5-nitro- 2,4-Dichloro-5-Nitropyridine(WXC02234) 4-chloro-5-methyl-3-nitropyridin-2-amine |
CAS | 4487-56-3 |
EINECS | 640-198-1 |
InChI | InChI=1/C5H2Cl2N2O2/c6-3-1-5(7)8-2-4(3)9(10)11/h1-2H |
InChIKey | RZVJQUMDJUUBBF-UHFFFAOYSA-N |
Molecular Formula | C5H2Cl2N2O2 |
Molar Mass | 192.99 |
Density | 1.629±0.06 g/cm3(Predicted) |
Melting Point | 42.0 to 46.0 °C |
Boling Point | 282.3±35.0 °C(Predicted) |
Flash Point | 124.548°C |
Solubility | soluble in Methanol |
Vapor Presure | 0.006mmHg at 25°C |
Appearance | powder to crystal |
Color | Light orange to Yellow to Green |
pKa | -2.49±0.10(Predicted) |
Storage Condition | Keep in dark place,Sealed in dry,Room Temperature |
Refractive Index | 1.603 |
MDL | MFCD07368834 |
Risk Codes | 25 - Toxic if swallowed |
Safety Description | 45 - In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) |
UN IDs | 2811 |
Hazard Class | 6.1 |
Packing Group | Ⅲ |
Application | 2,4-dichloro-5-nitropyridine is used to synthesize effective and selective stearoyl-CoA desaturase (SCD) inhibitors are also used to prepare Rho kinase inhibitors with antihypertensive activity. |